Betting on Regenerative Medicine
Hundreds of millions of VC funding are being funneled into regenerative medicine. The goal: To extend life to previously unattainable limits.
Last time on DiffuseTap, Mike Moradi, Managing Member at R3 Bio, talked to us about regenerative medicine and what it is, current trends and investment opportunities in this space in the aftermath of COVID, and how VCs should place their bets to avoid the potentially expensive pitfalls in the space.
A weekly virtual events series for GPs and LPs in alternative assets from across the globe where networking (you’ll bump into at least a dozen high-caliber fund managers) meets insights (you’ll DiffuseTap into brand-new investment ideas).